AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024. In the quarter to June 2026, revenue grew 6.26%, EPS fell 18.3%, free cash flow fell 23.1% and total debt rose 66.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten.

124.51 0.25 +0.20%
Market cap
$7.9B
P/E
22.2×
Fwd P/E
21.0×
Dividend yield
1.54%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

15.70% 15.19% 14.87% 13.52%
Piotroski F-Score
7 5 6 6
ROA
8.62% 8.11% 8.03% 7.25%
ROIC
8.64% 8.33% 8.18% 7.82%
Return on Tangible Assets
21.80% 16.34% 16.34% 15.46%
Average Days of Receivables
79.63 77.68 78.53 83.30
Free Cash Flow per Share
4.70 4.53 5.13 4.94
Free Cash Flow
308.70 298.11 328.66 314.58
Capital Expenditures
(255.84) (271.89) (277.29) (268.89)
Other line items
Cash ROIC
7.26% 6.51% 7.75% 7.47%
Accounts Receivable Turnover
4.89 5.17 4.91 4.63
Accounts Payable Turnover
2.80 3.06 3.06 2.95
Inventory Turnover
4.38 4.75 4.74 4.54
Average Days of Payables
136.01 126.60 125.14 128.80
Days of Inventory on Hand
88.13 82.75 82.08 84.21
Tax Rate
(0.19) (0.20) (0.19) (0.20)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
16.21% 16.06% 15.98% 15.90%
Share Based Compensation of Revenue
1.27% 1.16% 1.07% 1.04%
Interest Coverage
10.93 9.50 8.49 7.52
Operating CF/Net income
1.35 1.45 1.57 1.61
Depreciation/Fixed assets
0.17 0.17 0.18 0.19
Capex/Depreciation
(0.92) (0.95) (0.93) (0.88)
Revenue per Share
55.74 57.46 60.46 61.81
Operating CF per Share
8.59 8.67 9.46 9.17
Capex per Share
(3.89) (4.14) (4.33) (4.23)
Capex to Sales
0.07 0.07 0.07 0.07

Fold the line items

Columns are period end dates